1.. Introduction
================

In recent years, various nitrogen heterocyclic rings are known to exhibit interesting biological activities \[[@b1-ijms-15-08075]--[@b9-ijms-15-08075]\], such as triazole derivatives, thiazole derivatives, oxazole derivatives, and so on. 1,2,4-Triazole rings are typically planar aromatic systems, featuring an extensive chemistry \[[@b10-ijms-15-08075],[@b11-ijms-15-08075]\]. 1,2,4-Triazole derivatives represent one of the most biologically active classes of heterocyclic compounds, and their derivatives are characterized with a broad spectrum of biological activity, including anti-cancer activity \[[@b12-ijms-15-08075]\], antiparasitic activity \[[@b13-ijms-15-08075]\], larvicidal activity\[[@b14-ijms-15-08075]\], antifungal activity \[[@b15-ijms-15-08075]\], herbicidal activity \[[@b16-ijms-15-08075],[@b17-ijms-15-08075]\], antioxidant activity \[[@b18-ijms-15-08075]\], cytostatic activity \[[@b19-ijms-15-08075]\], brassinosteroid biosynthesis inhibitors \[[@b20-ijms-15-08075]\], antimicrobial activity \[[@b21-ijms-15-08075]\], and so on. Some compounds had been developed as commercial fungicides or herbicides ([Figure 1](#f1-ijms-15-08075){ref-type="fig"}), such as Triadimefon, Triadimenol, Flusilazole, Flupoxamand, and so on.

On the other hand, sulfur-linked 1,2,4-triazoles represent an important group of sulfur compounds that are promising for use in lead compound discovery, especially thione-substituted 1,2,4-triazole ring. Thus far, many bioactive sulfur-linked 1,2,4-triazole have been reported, such as antibacterial activity \[[@b22-ijms-15-08075],[@b23-ijms-15-08075]\], antitumor activity \[[@b24-ijms-15-08075]\], anti-HIV activity \[[@b25-ijms-15-08075]\], anti-TMV (tobacco mosaic virus) activity \[[@b26-ijms-15-08075]\], and so on.

Furthermore, pyridine is an important class of heterocyclic ring, which have attracted attention in past few years. The pyridine nucleus exists in numerous natural products and is extremely important in the chemistry of biological systems, such as antioxidant activity \[[@b27-ijms-15-08075]\], antimicrobial activity \[[@b28-ijms-15-08075]\], acetylcholinesterase inhibitors \[[@b29-ijms-15-08075]\], antibacterial activity \[[@b30-ijms-15-08075],[@b31-ijms-15-08075]\], anticancer activity \[[@b32-ijms-15-08075],[@b33-ijms-15-08075]\], anti-HBV activity \[[@b34-ijms-15-08075]\], and so on. In the fungicidal activity area, some pyridine derivatives can prevent *Ralstonia solanacearum* \[[@b35-ijms-15-08075]\], *Cerospora beticola sacc.* \[[@b36-ijms-15-08075]\], *Colletotrichum orbiculare* \[[@b37-ijms-15-08075]\], and so on. Currently, some pyridine compounds have been developed and commercialized, for example, Fluopicolid, Boscalid, Fluazinam, and Pyridinitril ([Figure 2](#f2-ijms-15-08075){ref-type="fig"}).

There are many reports about each of the two heterocycles, but the combination of the pyridine ring with the 1,2,4-triazole ring in one molecule is seldom reported both in chemistry and their biological activity studies. In view of the facts mentioned above, and also as a part of our work \[[@b38-ijms-15-08075]--[@b40-ijms-15-08075]\] on the synthesis of bioactive lead compounds, the title compounds were designed by introducing the pyridine ring pharmacophore into the 1,2,4-triazole scaffold. Twenty-one novel 1,2,4-triazole derivatives were synthesized and characterized by ^1^H NMR, MS and elemental analysis. The antifungal activities of these compounds were tested *in vivo.*

2.. Results and Discussion
==========================

2.1.. Chemistry
---------------

The synthesis procedures for title compounds were shown in [Scheme 1](#f5-ijms-15-08075){ref-type="fig"}. The intermediate **1** was synthesized easily from isonicotinic acid and alcohol under the concentrate, H~2~SO~4~, at refluxing condition. In addition, the intermediates **1** can be synthesized with high yield using SOCl~2~ or POCl~3~ as dehydrating agent. The intermediate **2** was easily given from ethyl isonicotinate and 85% hydrazine hydrate. The intermediate **3** can be obtained from the intermediate **2** and isothiocyanatobenzene. The intermediate **3** was easily cyclized to give intermediate **4** under alkaline condition, such as NaOH or KOH. The intermediate **4** is reacted with substituted benzyl chloride or alkyl chloride to afford compound **5**. The microwave irradiation assistant synthesis and conventional method was also employed in this experiment. NaOH/DMF/H~2~O system was applied under microwave irradiation. The best reaction condition is at 90 °C for 15 min under microwave irradiation synthesis. The yield is higher than that of conventional methods, and, in addition, the reaction time is shorter ([Table 1](#t1-ijms-15-08075){ref-type="table"}).

The signal of CH~2~ protons of thioether, neighboring the triazole ring, was observed at δ 2.23--4.67 ppm, respectively. The chemical shifts of pyridine are divided into two double peaks. The ESI (electrospray ionization)-MS spectrum showed that the *m*/*z* of molecular ion, in accordance with its molecular formula. The elemental analysis result is in accordance with the calculated results.

2.2.. Fungicidal Activities and Structure--Activity Relationship (SAR)
----------------------------------------------------------------------

The *in vivo* fungicidal results of title compounds against *Stemphylium lycopersici* (Enjoji) Yamamoto, *Fusarium oxysporum.* sp. cucumebrium, and *Botrytis cinerea* were listed in [Table 2](#t2-ijms-15-08075){ref-type="table"}, Zhongshengmycin, thiophanate-methyl, and cyprodinil were used as a control. As shown in [Table 2](#t2-ijms-15-08075){ref-type="table"}, many of the title compounds showed good control efficacy against *Stemphylium lycopersici* (Enjoji) Yamamoto at a concentration of 500 μg/mL, only compound **5b** exhibited weak activity (5.21%) against *Stemphylium lycopersici* (Enjoji) Yamamoto. Notably, when the R is the electron donating group at the para position of the benzene ring, it showed good activity against *Stemphylium lycopersici* (Enjoji) Yamamoto. For example, compound **5g** (71.43%) and **5h** (85.12%) displayed excellent inhibition against *Stemphylium lycopersici* (Enjoji) Yamamoto, respectively. In addition, for the alkyl substituted compounds, the longer chain, the lower the activity. The order is C~11~H~23~ \< C~4~H~9~ \< CH~2~CN \< CH~2~COOEt \< CH=CH~2~. All the title compounds exhibited moderate inhibition effect against *Fusarium oxysporum.* sp. cucumebrium and the fungicidal activities range is 48%--66%. Surprisingly, all these compounds showed weak activity against *Botrytis cinerea*.

2.3.. Molecular Total Energies and Frontier Orbital Energy Analysis
-------------------------------------------------------------------

Molecular total energy and frontier orbital energy levels are listed in [Table 3](#t3-ijms-15-08075){ref-type="table"}. The energy gap between HOMO and LUMO was calculated by B3LYP.

According to the frontier molecular orbital theory, HOMO and LUMO are the most important factors that affect the bioactivity. HOMO has the priority to provide electrons, while LUMO can accept electrons first \[[@b41-ijms-15-08075]\]. Thus, study on the frontier orbital energy can provide useful information about the biological mechanism. Taking the DFT (density functional theory) result for example, the geometry of the frame of the compound **5h** is hardly influenced by the introduction of, either the pyridine ring, 1,2,4-triazole ring, thioether group, or phenyl ring ([Figure 3](#f3-ijms-15-08075){ref-type="fig"}). The HOMO of the title compound is mainly located on the 4-OCH~3~ phenyl ring, 1,2,4-triazole ring, and thioether group. While, the LUMO of the title compound is located on the pyridine ring, 1,2,4-triazole ring, thioether group. The fact that the title compound has strong affinity suggests the importance of the frontier molecular orbital in the π--π stacking or hydrophobic interactions. This also implies that the orbital interaction between the title compound and the aromatic ring or some other side of residue chains of receptors is dominated by π--π or hydrophobic interaction among the frontier molecular orbitals.

2.4.. Mulliken Atomic Charges and Electrostatic Potential Analyses
------------------------------------------------------------------

[Table 4](#t4-ijms-15-08075){ref-type="table"} exhibits the calculated Mulliken atomic charges except for atoms H. Taking DFT, for example, again, four atoms S18, C3, C23, and C27 are the most positively charged ones, which can interact with the negative charged part of the receptor easily. The negative charges are mainly located on atoms N1, N2, N4, N14, and O29, so they can interact easily with the positive part of the receptor. Therefore, we supposed this compound can combine the amino-acid residue on its surface by the interaction of the pyridine, triazole sulfur ether group, and OCH~3~ group, which may be responsible for the bioactivity.

Electrostatic potential of title compound was also calculated. From [Figure 4](#f4-ijms-15-08075){ref-type="fig"}, both oxygen atoms and nitrogen atoms have more negative charges. Perhaps the oxygen atoms and nitrogen atoms had some interaction with the receptor or acceptor.

3.. Experimental Section
========================

3.1.. Materials and Reagents
----------------------------

All the reagents are of analytical grade or freshly prepared before use. The monitoring of the progress of all reactions and homogeneity of the synthesized compounds were carried out by thin layer chromatography (TLC), TLC analysis was performed on silica gel plate, which was obtained from Qingdao Ocean Chemicals (Qingdao, China). Melting points were determined using an X-4 apparatus (Taike, Beijing, China) and uncorrected (Taike, Beijing, China). ^1^H NMR spectra were measured on a Bruker AV 400 or 500 (Bruker, Fallanden, Switzerland) instrument using TMS as an internal standard and CDCl~3~ as the solvent. Mass spectra were recorded on a Thermo Finnigan LCQ Advantage LC/mass detector instrument (Thermo Finnigan, Waltham, MA, USA). Elemental analyses were performed on a Vario EL elemental analyzer (ELEMENTAR, Hanau, Germany). Microwave activation was carried out with CEM Discover™ focused microwave (2450 MHz, 300 W, CEM, Matthews, NC, USA).

3.2.. Theoretical Calculations
------------------------------

On the basis of the above structure, an isolated molecule was selected as the initial structure, while DFT-B3LYP/6-31G (*d*,*p*) methods in Gaussian 03 package \[[@b42-ijms-15-08075]\] were used to optimize the structure of the title compound. Vibration analysis showed that the optimized structures were in accordance with the minimum points on the potential energy surfaces. All the convergent precisions were the system default values, and all the calculations were carried out on a personal computer.

3.3.. Chemical Synthesis
------------------------

### Synthesis of Intermediates

#### Ethyl Isonicotinate (**1**)

A mixture of isonicotinic acid (1.23 g, 10 mmol), 20 mL of ethanol, and 0.5 mL of H~2~SO~4~ were fluxed for 12 h in a 100 mL round-bottomed flask. After ethanol was evaporated under reduced pressure, about 20 mL of Na~2~CO~3~ solution (1 M) was added into the mixture. Then the mixture was extracted with ether. After evaporation of the solvent, the product **1** was obtained. Colorless liquid, yield: 90%.

#### Isonicotinyi Hydrazine (**2**)

A mixture of ethyl isonicotinate (1.44 g, 10 mmol) and 85% hydrazine hydrate (2 mL, 35 mmol) was heated under reflux for 6 h. The mixture was cooled to room temperature, filtered, washed with cool ethyl acetate, then dried to give white solid isonicotinyi hydrazine **2**. Yield (1.0 g, 73%).

#### 2-(4-Methyl-1, 2, 3-thiadiazole-5-carbonyl)-*N*-phenylhydrazinecarbothioamide (**3**)

A mixture of isonicotinyi hydrazine (1.37 g, 10 mmol) with isothiocyanatobenzene (1.35 g, 10 mmol) was refluxed for 5 h in ethanol. After cooling down to room temperature, the products were obtained and recrystallized from methanol to give **3**, yield 95%.

#### 5-Pyridyl-4-phenyl-4*H*-1,2,4-triazole-3-thiol (**4**)

A mixture of compound **3** (10 mmol) in aqueous NaOH solution (5 mL, 2 N) was refluxed for 4 h. After cooling down to room temperature, HCl aqueous solution (4 N) was added to afford a large amount of precipitate. The solid was filtered, dried and recrystallized from methanol to give intermediate **4**, yield 88%.

#### General Procedure for Thioether (**5**)

A CEM designed 10 mL pressure-rated vial was charged with DMF (5 mL), **4** (0.25 g, 1 mmol), RCH~2~Cl (1.1 mmol), and NaOH (0.05 g, 1.2 mmol). The mixture was irradiated in a CEM Discover Focused Synthesizer (150 w, 90 °C, 200 psi, 15 min). The mixture was cooled to room temperature by passing compressed air through the microwave cavity for 2 min. It was poured into cold ice (40 mL) and the formed precipitate was filtered. The crude solid was recrystallized from EtOH to give the title compounds **5a**. All the other compounds are synthesized according to the procedure.

#### 4-((5-(2,4-Dichlorobenzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5a**)

White crystal, yield 83%, m.p. 184--186 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.61 (s, 2H, SCH~2~), 7.17 (d, *J* = 7.5 Hz, 2H, Py), 7.20 (d, *J* = 8.3 Hz, 2H, Ph), 7.28--7.38 (m, 3H, ArH), 7.39 (s, 1H, ArH), 7.55--7.63 (m, 4H, ArH), 8.55 (d, *J* = 5.8 Hz, 2H, Py). MS (ESI), *m*/*z*: 414 (M + 1)^+^. Elemental analysis (%), calculated: C, 58.12; H, 3.41; N, 13.56; found: C, 58.22; H, 3.12; N, 13.43.

#### 3-(((4-Phenyl-5-(pyridin-4-yl)-4*H*-1,2,4-triazol-3-yl)thio)methyl)benzonitrile (**5b**)

White crystal, yield 90%, m.p. 179--181 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.54 (s, 2H, SCH~2~), 7.16 (d, *J* = 7.1 Hz, 2H, Py), 7.30 (d, *J* = 6.0 Hz, 2H, ArH), 7.40 (t, *J* = 7.7 Hz, 1H, ArH), 7.52--7.59 (m, 4H, ArH), 7.67--7.69 (m, 2H, ArH), 8.55 (d, *J* = 5.5 Hz, 2H, Py). MS (ESI), *m*/*z*: 370 (M + 1)^+^. Elemental analysis (%), calculated: C, 68.27; H, 4.09; N, 18.96; found: C, 68.34; H, 3.98; N, 19.01.

#### 4-((5-(2-Fluorobenzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5c**)

White crystal, yield 86%, m.p. 166--168 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.57 (s, 2H, SCH~2~), 7.00--7.11 (m, 2H, Ar-H), 7.17 (d, *J* = 7.4 Hz, 2H, ArH), 7.27--7.32 (m, 3H, ArH), 7.51--7.57 (m, 4H, ArH), 8.55 (t, *J* = 6.1 Hz, 2H, Py). MS (ESI), *m*/*z*: 363 (M + 1)^+^. Elemental analysis (%), calculated: C, 66.28; H, 4.17; N, 15.46; found: C, 66.55; H, 4.25; N, 15.64.

#### 4-(((4-Phenyl-5-(pyridin-4-yl)-4*H*-1,2,4-triazol-3-yl)thio)methyl)benzonitrile (**5d**)

White crystal, yield 88%, m.p. 160--162 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.56 (s, 2H, SCH~2~), 7.19 (d, *J* = 7.4 Hz, 2H, Py), 7.34 (d, *J* = 4.8 Hz, 2H, ArH), 7.56--7.63 (m, 7H, ArH), 8.56 (d, *J* = 4.9 Hz, 2H, Py). MS (ESI), *m*/*z*: 370 (M + 1)^+^. Elemental analysis (%), calculated: C, 68.27; H, 4.09; N, 18.96; found: C, 68.42; H, 4.13; N, 18.88.

#### 2-Chloro-5-(((4-phenyl-5-(pyridin-4-yl)-4*H*-1,2,4-triazol-3-yl)thio)methyl)pyridine (**5e**)

White crystal, yield 88%, m.p. 184--186 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.51 (s, 2H, SCH~2~), 7.20 (d, *J* = 7.5 Hz, 2H, Py), 7.27 (d, *J* = 7.5 Hz, 1H, Py), 7.44 (d, *J* = 6.2 Hz, 2H, ArH), 7.56--7.63 (m, 3H, ArH), 7.82 (d, *J* = 8.2 Hz, 1H, Py), 8.40 (s, 1H, Py), 8.58 (t, *J* = 5.9 Hz, 2H, Py). MS (ESI), *m*/*z*: 381 (M + 1)^+^. Elemental analysis (%), calculated: C, 60.07; H, 3.71; N, 18.44; found: C, 59.99; H, 3.65; N, 18.58.

#### 4-(5-((3-Chlorobenzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5f**)

White crystal, yield 84%, m.p. 153--155 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.46 (s, 2H, SCH~2~), 7.15 (d, *J* = 7.6 Hz, 2H, Py), 7.21--7.36 (m, 6H, ArH), 7.52--7.60 (m, 3H, ArH), 8.55 (d, *J* = 4.3 Hz, 2H, Py). MS (ESI), *m*/*z*: 380 (M + 1)^+^. Elemental analysis (%), calculated: C, 63.40; H, 3.99; N, 14.79; found: C, 63.31; H, 3.78; N, 14.98.

#### 4-(5-((4-(*Tert*-butyl)benzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5g**)

White crystal, yield 91%, m.p. 199--200 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 1.31 (s, 9H, Bu), 4.52 (s, 2H, SCH~2~), 7.13 (d, *J* = 7.6 Hz, 2H, Py), 7.28--7.35 (m, 5H, ArH), 7.49--7.57 (m, 4H, ArH), 8.55 (d, *J* = 6.0 Hz, 2H, Py). MS (ESI), *m*/*z*: 401 (M + 1)^+^. Elemental analysis (%), calculated: C, 71.97; H, 6.04; N, 13.99; found: C, 72.21; H, 6.15; N, 14.21.

#### 4-(5-((4-Methoxybenzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5h**)

White crystal, yield 89%, m.p. 114--116 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 3.80 (s, 3H, OMe), 4.50 (s, 2H, SCH~2~), 6.83 (d, *J* = 8.6 Hz, 2H, ArH), 7.16 (d, *J* = 7.4 Hz, 2H, Py), 7.28--7.36 (m, 4H, ArH), 7.50--7.58 (m, 3H, ArH), 8.55 (d, *J* = 6.1 Hz, 2H, Py). MS (ESI), *m*/*z*: 375 (M + 1)^+^. Elemental analysis (%), calculated: C, 67.36; H, 4.85; N, 14.96; found: C, 67.44; H, 4.98; N, 14.87.

#### 4-(5-((3,4-Dichlorobenzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5i**)

White crystal, yield 83%, m.p. 135--137 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.50 (s, 2H, SCH~2~), 6.84 (d, *J* = 8.6 Hz, 2H, Ar-H), 7.17 (d, *J* = 7.4 Hz, 2H, Py), 7.28--7.31 (m, 3H, Ar-H), 7.50--7.58 (m, 3H, ArH), 8.54 (d, *J* = 6.0 Hz, 2H, Py). MS (ESI), *m*/*z*: 414 (M + 1)^+^. Elemental analysis (%), calculated: C, 58.12; H, 3.41; N, 13.56; found: C, 58.33; H, 3.12; N, 13.43.

#### 4-(5-((2-Chlorobenzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5j**)

White crystal, yield 89%, m.p. 155--157 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.65 (s, 2H, SCH~2~), 7.14 (d, *J* = 7.6 Hz, 2H, Py), 7.21--7.37 (m, 5H, ArH), 7.51--7.61 (m, 4H, ArH), 8.55 (d, *J* = 5.0 Hz, 2H, Py). MS (ESI), *m*/*z*: 380 (M + 1)^+^. Elemental analysis (%), calculated: C, 63.40; H, 3.99; N, 14.79; found: C, 63.63; H, 4.02; N, 14.88.

#### 4-(5-((4-Bromobenzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5k**)

White crystal, yield 90%, m.p. 161--163 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.48 (s, 2H, SCH~2~), 7.15 (d, *J =* 7.2 Hz, 2H, Py), 7.28--7.32 (m, 4H, ArH), 7.42 (d, *J =* 8.3 Hz, 2H, Ar-H), 7.51--7.60 (m, 3H, ArH). 8.60 (bs, 2H, Py). MS (ESI), *m*/*z*: 424 (M + 1)^+^. Elemental analysis (%), calculated: C, 56.74; H, 3.57; N, 13.23; found: C, 56.87; H, 3.67; N, 13.43.

#### 4-(5-((4-Chlorobenzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5l**)

White crystal, yield 88%, m.p. 163 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.50 (s, 2H, SCH~2~), 7.15 (d, *J =* 7.6 Hz, 2H, Py), 7.27--7.35 (m, 6H, ArH), 7.51--7.57 (m, 3H, Ar), 8.55 (d, *J =* 6.0 Hz, 2H, Py). MS (ESI), *m*/*z*: 380 (M + 1)^+^. Elemental analysis (%), calculated: C, 63.40; H, 3.99; N, 14.79; found: C, 63.51; H, 4.21; N, 14.65.

#### 4-(5-(Butylthio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5m**)

White crystal, yield 86%, m.p. 147--149 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 0.94 (t, *J =* 7.4 Hz, 3H, CH~3~), 1.41--1.51 (m, 2H, CH~2~), 1.73--1.81 (m, 2H, CH~2~), 3.23 (t, *J =* 7.4 Hz, 2H, SCH~2~), 7.28--7.29 (m, 1H, Ar-H), 7.31 (d, *J =* 6.0 Hz, 2H, Py), 7.54--7.62 (m, 3H, ArH), 8.55 (d, *J =* 5.7 Hz, 2H, Py). MS (ESI), *m*/*z*: 380 (M + 1)^+^. Elemental analysis (%), calculated: C, 65.78; H, 5.84; N, 18.05; found: C, 65.87; H, 5.99; N, 17.98.

#### 2-Chloro-5-(((4-phenyl-5-(pyridin-4-yl)-4*H*-1,2,4-triazol-3-yl)thio)methyl)thiazole (**5n**)

White crystal, yield 88%, m.p. 199--202 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.67 (s, 2H, SCH~2~), 7.22 (d, *J =* 7.3 Hz, 2H, Py), 7.38 (d, *J =* 6.2 Hz, 2H, Ar), 7.51 (s, H, thiazole-H), 7.56--7.64 (m, 3H, ArH), 8.55 (d, *J =* 6.0 Hz, 2H, Py). MS (ESI), *m*/*z*: 387 (M + 1)^+^. Elemental analysis (%), calculated: C, 52.91; H, 3.13; N, 18.15; found: C, 52.89; H, 3.12; N, 18.32.

#### 2-((4-Phenyl-5-(pyridin-4-yl)-4*H*-1,2,4-triazol-3-yl)thio)acetonitrile (**5o**)

White crystal, yield 79%, m.p. 237--240 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.15 (s, 2H, SCH~2~), 7.30--7.31 (m, 4H, ArH and Py), 7.60--7.67 (m, 3H, ArH), 8.59 (d, *J =* 4.3 Hz, 2H, Py). MS (ESI), *m*/*z*: 294 (M + 1)^+^. Elemental analysis (%), calculated: C, 61.42; H, 3.78; N, 23.87; found: C, 61.38; H, 3.67; N, 23.98.

#### (*E*)-Methyl-2-(methoxyimino)-2-(2-(((4-phenyl-5-(pyridin-4-yl)-4*H*-1,2,4-triazol-3-yl)thio)methyl) phenyl)acetate (**5p**)

White crystal, yield 82%, m.p. 140--144 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 3.61 (s, 3H, CH~3~), 3.78 (s, 3H, CH~3~), 4.48 (s, 2H, SCH~2~), 7.11--7.18 (m, 3H, ArH and Py), 7.27--7.32 (m, 4H, ArH), 7.47--7.56 (m, 4H, ArH), 8.56 (d, *J =* 4.6 Hz, 2H, Py). MS (ESI), *m*/*z*: 459 (M + 1)^+^. Elemental analysis (%), calculated: C, 65.48; H, 4.84; N, 12.22; found: C, 65.65; H, 5.01; N, 12.33.

#### 4-(5-((3-Fluorobenzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5q**)

White crystal, yield 86%, m.p. 146--148 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 4.52 (s, 2H, SCH~2~), 6.98 (t, *J =* 8.3 Hz, 1H, ArH), 7.12 (d, *J =* 9.6 Hz, 1H, ArH), 7.17 (d, *J =* 7.6 Hz, 2H, Py), 7.25--7.32 (m, 4H, ArH), 7.52--7.60 (m, 3H, ArH), 8.55 (d, *J =* 6.2 Hz, 2H, Py). MS (ESI), *m*/*z*: 363 (M + 1)^+^. Elemental analysis (%), calculated: C, 66.28; H, 4.17; N, 15.46; found: C, 66.42; H, 4.44; N, 15.64.

#### 4-(5-((2-Methylbenzyl)thio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5r**)

White crystal, yield 86%, m.p. 173--174 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 2.35 (s, 3H, Me), 4.50 (s, 2H, SCH~2~), 7.10--7.17 (m, 4H, ArH and Py), 7.29--7.59 (m, 7H, ArH), 8.57 (d, *J =* 5.8 Hz, 2H, Py). MS (ESI), *m*/*z*: 359 (M + 1)^+^. Elemental analysis (%), calculated: C, 70.36; H, 5.06; N, 15.63; found: C, 70.15; H, 4.99; N, 15.76.

#### 4-(4-Phenyl-5-(undecylthio)-4*H*-1,2,4-triazol-3-yl)pyridine (**5s**)

White crystal, yield 84%, m.p. 82--84 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 0.89 (t, *J =* 6.6 Hz, 3H, CH~3~), 1.24--1.45 (m, 16H, CH~2~), 1.74--1.82 (m, 2H, CH~2~), 3.32 (t, *J =* 7.3 Hz, 2H, SCH~2~), 7.28--7.33 (m, 4H, Ar-H and Py-H), 7.54--7.62 (m, 3H, ArH), 8.54 (d, *J =* 4.9 Hz, 2H, Py). MS (ESI), *m*/*z*: 409 (M + 1)^+^. Elemental analysis (%), calculated: C, 70.55; H, 7.89; N, 13.71; found: C, 70.80; H, 8.02; N, 13.56.

#### 4-(5-(Allylthio)-4-phenyl-4*H*-1,2,4-triazol-3-yl)pyridine (**5t**)

White crystal, yield 88%, m.p. 167--169 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 3.95 (d, *J =* 7.1 Hz, 2H, SCH~2~), 5.19 (d, *J =* 10.0 Hz, 1H, =CH~2~), 5.34 (d, *J =* 15.9 Hz, 1H, =CH~2~), 5.94--6.00 (m, 1H, =CH), 7.27--7.33 (m, 4H, ArH and Py), 7.55--7.60 (m, 3H, ArH), 8.55 (d, *J =* 5.9 Hz, 2H, Py). MS (ESI), *m*/*z*: 295 (M + 1)^+^. Elemental analysis (%), calculated: C, 65.28; H, 4.79; N, 19.03; found: C, 65.42; H, 4.90; N, 19.09.

#### Ethyl-2-((4-phenyl-5-(pyridin-4-yl)-4*H*-1,2,4-triazol-3-yl)thio)acetate (**5u**)

White crystal, yield 92%, m.p. 162--164 °C; ^1^H NMR (CDCl~3~, 400 MHz), δ: 1.27 (t, *J =* 7.1 Hz, 3H, Me), 4.12 (s, 2H, SCH~2~), 4.22 (q, *J =* 7.1 Hz, 2H, CH~2~), 7.30--7.33 (m, 4H, ArH and Py), 7.55--7.60 (m, 3H, ArH), 8.55 (d, *J =* 4.6 Hz, 2H, Py). MS (ESI), *m*/*z*: 341 (M + 1)^+^. Elemental analysis (%), calculated: C, 59.98; H, 4.74; N, 16.46; found: C, 59.89; H, 4.99; N, 16.55.

3.4.. Fungicidal Activities
---------------------------

Fungicidal activity of compounds **5a**--**5u** against *Stemphylium lycopersici* (Enjoji) Yamamoto*, Fusarium oxysporum.* sp. cucumebrium, and *Botrytis cinerea* were evaluated according to reference, and a potted plant test method was adopted. Germination was conducted by soaking cucumber seeds in water for 2 h at 50 °C and then keeping the seeds moist for 24 h at 28 °C in an incubator. When the radicles were 0.5 cm, the seeds were grown in plastic pots containing a 1:1 (*v*/*v*) mixture of vermiculite and peat. Cucumber and tomato plants used for inoculations were at the stage of two seed leaves. Tested compounds and commercial fungicides were sprayed with a hand sprayer on the surface of the seed leaves on a fine morning, at the standard concentration of 500 μg/mL, zhongshengmycin, thiophanate-methyl and cyprodinil were used as a control. After 2 h, inoculations of *Stemphylium lycopersici* (Enjoji) Yamamoto was carried out by spraying fungal suspension, inoculation of *Fusarium oxysporum.* sp. cucumebrium was carried out by spraying mycelial suspension, inoculation of *Botrytis cinerea* was carried out by radicle soaking. The experiment was repeated 4 times. After inoculation, the plants were maintained at 18--30 °C (mean temperature of 24 °C and above 80% relative humidity (RH)). The fungicidal activities were evaluated when the nontreated cucumber plant (blank) fully developed symptoms. The area of inoculated treated leaves covered by disease symptoms was assessed and compared to those of nontreated ones to determine the average disease index. The relative control efficacy of compounds compared to the blank assay was calculated via the following equation:
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where *CK* is the average disease index during the blank assay and *PT* is the average disease index after treatment during testing.

4.. Conclusions
===============

In summary, a series of 1,2,4-triazole derivatives were synthesized containing pyridine ring in good yields. The preliminary bioassays showed that some of the compounds had good fungicidal activity. The present findings provided a powerful complement to the SARs of fungicides, and warrant future investigation of the mechanism of action of these analogs.
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###### 

Comparison of yields of **5a** through methods with or without microwave (MW) irradiation.

  No.      Method   Time     Temperature/°C   Yield/%
  -------- -------- -------- ---------------- ---------
  **5a**   No-MW    24 h     r.t.             80
  **5a**   No-MW    10 min   90               38
  **5a**   MW       10 min   90               81
  **5a**   MW       15 min   90               83
  **5a**   MW       20 min   90               83

###### 

The antifungal activity (%) of title compounds *in vivo* at 500 ppm.

  No.                  *Stemphylium lycopersici* (Enjoji) Yamamoto   *Fusarium oxysporum.* sp. cucumebrium   *Botrytis cinerea*
  -------------------- --------------------------------------------- --------------------------------------- --------------------
  **5a**               53.57                                         66.67                                   24.44
  **5b**               5.21                                          64.86                                   20.42
  **5c**               50.30                                         65.56                                   28.89
  **5d**               33.04                                         66.67                                   23.33
  **5e**               43.15                                         64.44                                   24.44
  **5f**               46.23                                         66.94                                   14.44
  **5g**               71.43                                         63.93                                   20.00
  **5h**               85.12                                         64.44                                   20.00
  **5i**               73.51                                         63.33                                   16.67
  **5j**               62.20                                         66.67                                   15.56
  **5k**               42.86                                         64.44                                   6.67
  **5l**               66.98                                         64.44                                   17.78
  **5m**               54.17                                         64.81                                   26.67
  **5n**               46.58                                         65.56                                   10.00
  **5o**               65.67                                         48.89                                   13.33
  **5p**               66.07                                         54.44                                   15.56
  **5q**               67.86                                         53.33                                   22.22
  **5r**               75.00                                         53.33                                   15.56
  **5s**               51.79                                         53.33                                   12.22
  **5t**               79.76                                         55.56                                   12.22
  **5u**               75.89                                         48.89                                   20.00
                                                                                                             
  Zhongshengmycin      59.58                                                                                 
  Thiophanate-Methyl                                                 81.69                                   
  Cyprodinil                                                                                                 45.56

###### 

Total energy, frontier orbital energy. DFT, density functional theory; LUMO, lowest unoccupied molecular orbital; HOMO, highest occupied molecular orbital.

  *E*                                                                DFT
  ------------------------------------------------------------------ ----------------
  *E*~total~/Hartree [b](#tfn2-ijms-15-08075){ref-type="table-fn"}   −1503.11499092
  *E*~HOMO~/Hartree                                                  −0.21450
  *E*~LUMO~/Hartree                                                  −0.05529
  Δ*E* [a](#tfn1-ijms-15-08075){ref-type="table-fn"}/Hartree         0.15921

Δ*E*= *E*~LUMO~ − *E*~HOMO~;

Hartree = 4.35974417 × 10^−18^, J = 27.2113845 eV.

###### 

Mulliken atomic charges except for atoms H (e).

  ----- -----------
  S18   0.326749
  N14   −0.359494
  N4    −0.757709
  N2    −0.319626
  N1    −0.308887
  C16   0.035720
  C15   0.125270
  C13   0.135365
  C12   0.056497
  C17   0.127367
  C3    0.361752
  C5    0.175208
  C6    0.170471
  C7    0.092394
  C8    −0.002097
  C9    0.040403
  C10   −0.001456
  C11   0.093994
  C19   −0.146321
  C20   0.128847
  C21   −0.032559
  C22   −0.012577
  C23   0.287098
  C24   0.008964
  C25   0.034697
  O26   −0.557033
  C27   0.296964
  ----- -----------
